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Purpose: Autophagy has been reported to be involved in treatment failure in tu-
mor. We aimed to evaluate autophagy activity in tumor tissue and compare them 
between the recurrence and non-recurrence groups. Materials and Methods: We 
analyzed expressions of autophagy-related proteins in tumor tissues which were 
obtained from pulmonary metastases of colorectal cancer patients by Western blot. 
We also analyzed autophagosomes by transmission electron microscopy. Results: 
Tumor tissues from recurrence group showed increased levels of LC3B-II, de-
creased levels of p62/SQSTM1, and also a marked accumulation of autophago-
somes compared with tissues from non-recurrence group. Conclusion: The pres-
ent study suggests that autophagy may be associated with treatment failure of 
metastatic colorectal cancer.
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INTRODUCTION
Autophagy is a catabolic digestion process of cellular organelles1 and plays an im-
portant role in protecting cells from adverse conditions2-6 by degrading and recy-
cling of cytosolic, or aggregated proteins, as well as excess or defective organelles. 
The process of autophagy has been implicated in both cellular survival and cell 
death.7,8 The role of autophagy in tumor is commonly expressed by double-edged 
sword.9,10 Before the development of a tumor, autophagy is considered to act as a 
tumor suppressor; however, after tumor develops, it supports the growth of the tu-
mor. Specifically, autophagy activities have been reported to be enhanced in re-
sponse to metabolic stress caused by chemotherapy or radiation as a cell survival 
mechanism, contributing to treatment resistance in cancer.9-12 Furthermore, elevat-
ed autophagy activity has been reported to be associated with aggressiveness in 
cancer tissue.13
Colorectal cancer (CRC) brings about metastases in 60% of the cases, with in-
volvement of the liver (40%), lung (15%), or both (10%).14 Although development 
of chemotherapeutic regimens combined with surgical resection has made it possi-
ble to treat the metastatic CRC, half of patients develop local or distant recur-
rence.15 The treatment failure in some individuals is due to the development of re-
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anti-rabbit secondary antibody (1:2000 dilution in TBST, 
Santa Cruz, CA, USA) at 37°C for 1 hour and were washed 
five times with TBST for 10 minutes each at room tempera-
ture. Membranes were treated with ECL (Thermo Scientific, 
Rockford, IL, USA) reagent and exposed to photographic 
film. Each band was quantified using densitometry, and the 
results were shown as relative expression of each protein 
from different samples compared to that of control sample.
Electron microscopy
After thermal stresses for 12 hours, each sample was fixed 
with 2% glutaraldehyde‒paraformaldehyde in 0.1 M phos-
phate buffer (PB), pH 7.4 for 2 hours and washed three 
times for 30 minutes each in 0.1 M PB. Samples were then 
postfixed with 1% OsO4 dissolved in 0.1 M PB for 2 hours 
and dehydrated in an ascending gradual series (50‒100%) 
of ethanol and infiltrated with propylene oxide. Specimens 
were embedded using a Poly/Bed 812 kit. After pure fresh 
resin embedment and polymerization at 60°C in an electron 
microscope oven (TD-700, DOSAKA, Kyoto, Japan) for 
24 hours, 350 nm thick sections were cut and stained with 
toluidine blue for light microscopy. Next, 70 nm thin sec-
tions were double stained with 7% uranyl acetate and lead 
citrate for contrast staining. The sections were cut by a LEI-
CA Ultracut UCT Ultra-microtome (Leica Microsystems, 
Wetzlar, Germany). All of the thin sections were observed 
by transmission electron microscopy (JEM-1011, JEOL, 
Tokyo, Japan) at an acceleration voltage of 80 kV.
Statistical analysis
The data were expressed as mean±SEM. Statistical analysis 
was performed using Student’s t-test. The criterion for sta-
tistical significance was p<0.05.
RESULTS
 
Patients characteristics
Clinical features of the cases are summarized in Table 1. 
Five patients experienced recurrence during the follow up 
time. All recurrences occurred in lung except one case. All 
10 patients had been treated by pulmonary resection and 
chemotherapy before or after operation. 
Elevated autophagy activity correlates with treatment 
failure of pulmonary metastasis from CRC
To investigate whether autophagy activity correlates with 
sistance, and the mechanisms involved in chemotherapy 
resistance remain unknown.
We hypothesized that autophagy may contribute to the 
treatment failure of cancer patients. To test this hypothesis, 
we investigated the autophagy activity in tumor tissue ob-
tained from patients who had pulmonary metastasis from 
CRC.
MATERIALS AND METHODS
Patients and samples
To test autophagy-related activity in tumor tissue, 10 pulmo-
nary metastasis tissues from CRC patients who had over 12 
months follow up period were selected from prospective col-
lections of the Department of Thoracic and Cardiovascular 
Surgery, Yonsei University College of Medicine. Patients un-
derwent curative intent pulmonary resection for metastasis 
from CRC from November 2011. Clinical records were re-
viewed retrospectively. The research has been approved by 
the Institutional Review Board of Yonsei University College 
of Medicine, and all the patients had signed an informed con-
sent. Tumor specimens were obtained at surgery. The speci-
mens were prepared for protein extraction and electron mi-
croscopy.
Protein extraction and Western blotting of tumor tissues
Tumor tissues were homogenized in 1 mL of RIPA buffer 
(50 mM Tris-HCl, pH 7.5, 0.1% SDS, 2 mM EDTA, 150 
mM NaCl, 1% sodium deoxycholate, 1% Triton X-100) and 
protease inhibitor cocktail. The homogenate was incubated 
for 20 minutes on ice and then centrifuged at 14000 rpm for 
15 minutes at 4°C. The supernatant was collected and the 
same volume of 5X SDS buffer was added to the superna-
tant. The mixture was then boiled for 5 minutes and stored at 
-80°C. Proteins were separated by sodium dodecy1 sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) on 8‒16% 
polyacrylamide gels. After electrophoresis, proteins were 
transferred to PVDF membranes (Millipore Corporation, Bil-
lerica, MA, USA), membranes were blocked in 5% nonfat 
milk, in Tris-buffered saline containing 0.05% Tween-20 
(TBST), at room temperature for 1 hour. The membranes 
were then incubated with a rabbit monoclonal antibody 
against LC3 (1:2000 diluted in TBST, Novus, Santa Cruz, 
CA, USA) overnight at 4°C and washed five times with 
TBST for 10 minutes each at room temperature. Membranes 
were then incubated with horseradish peroxidase-conjugated 
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tophagosomes in cells of treatment failed patients (p<0.05), 
where cytoplasmic material and/or membrane vesicles were 
encapsulated in vacuoles (black arrows, Fig. 4). These re-
sults indicate that increased autophagy activity is associated 
with treatment failure in patients after combined chemo-
therapy and surgical resection.
DISCUSSION
In this study, we showed that autophagy activities were en-
hanced in tumor tissue from recurrence group compared 
with non-recurrence group, suggesting that autophagy ac-
tivity could be one of the mechanisms associated with treat-
ment failure in patients with pulmonary metastasis from 
colorectal cancer. To the best of our knowledge, the present 
study is the first to correlate autophagy activity and treat-
ment failure in tumor tissue obtained from pulmonary me-
tastasis of colorectal cancer.
Autophagy is a catabolic digestion process of cellular or-
treatment failure in patients with pulmonary metastasis 
from CRC, we analyzed the protein level of LC3B-II which 
is a hallmark of autophagy by Western blotting. Tumor tis-
sues of patients who experienced recurrence showed in-
creased level of LC3B-II compared with tissues from pa-
tients who had no recurrence (p<0.05) (Fig. 1). At the same 
time, we analyzed the protein levels of p62/sequestosome1 
(SQSTM1) which is degraded in the autolysosome, thus 
testing an another marker of autophagy flux. Tumor tissues 
of patients who experienced recurrence showed trends of 
decreased level of p62/SQSTM1 compared with tissues 
from patients who had no recurrence (p=0.201) (Fig. 2). On 
the other hand, autophagy activity of peri-tumor tissue 
showed no difference between no recurrence and recur-
rence group (p=0.797) (Fig. 3).
Enhanced autophagy vacuoles in treatment failed 
patients
Transmission electron microscopy, another gold standard as-
say of autophagy showed a marked accumulation of au-
Table 1. Patients Profile 
  No. Age/sex Primary lesion
Treatment 
for pulmonary 
metastasis
Chemotherapeutic 
regimen
Tumor size 
(mm)
Recurrence
Recurrence 
site
Recurrence 
free time 
(months) 
  1 74/male Rectal cancer C+Op+C Xeloda   7 No - 23.67
  2 52/female Colon cancer Op+C FOLFOX   6 No - 20.00
  3 51/male Rectal cancer Op+C FL 70 No - 17.50
  4 57/male Rectal cancer Op+C FL 40 No - 16.57
  5 75/male Rectal cancer C+Op FL 12 No - 12.20
  6 58/male Rectal cancer C+Op FOLFOX 18 Yes Lung   2.43
  7 69/male Rectal cancer Op+C FOLFOX 12 Yes Lung   7.77
  8 62/male Rectal cancer C+Op+C FL 15 Yes Lung   9.27
  9 54/male Colon cancer C+Op FOLFOX 17 Yes Lung   1.70
10 54/male Colon cancer Op+C FOLFOX 10 Yes Abdominal LN   0.77
C, chemotherapy; Op, pulmonary resection; FOLFOX, 5-fluorouracil+leukovorin+oxaliplatin; FL, 5-fluorouracil+leucovorin.
Fig. 1. Increased autophagy activity (LC3II) correlates with treatment failure of pulmonary metastasis in colorectal cancer patients. (A) Western blot analysis 
for LC3B-II protein in tumors of CRC patients. The levels of LC3B-II were higher in tumor tissues from patients who had experienced recurrence than tissues 
from patients who had no recurrence. (B) Expression intensity of Western blot was measured by image J program. The data are mean±SEM (*p<0.05). CRC, 
colorectal cancer; SEM, standard error of mean.
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toplasmic form (LC3B-I) is processed and recruited to au-
tophagosomes, where LC3B-II is produced by proteolysis 
and lipidation. The protein p62/SQSTM1 acts as an adaptor 
to target ubiquinated protein by binding both ubiquitin and 
LC3.16 Following the binding of p62/SQSTM1 to LC3B-II, 
the autophagosome completes and fuses with lysosomes, 
resulting in the degradation of p62/SQSTM1. Thus, p62/
ganelles1 and essential for protecting cells from adverse 
conditions.2-6 The process of autophagy has been implicated 
in both cellular survival and cell death.7,8 Cytoplasmic or-
ganelles are engulfed by double membrane structures and 
conveyed to lysosomes/vacuoles for degradation and recy-
cling during the process. LC3 is autophagy-related protein 
that is associated with autophagosome membranes. The cy-
Fig. 4. Autophagy vacuoles in tumor tissue from pulmonary metastasis in colorectal cancer patients by electron microscopy. (A) Electron micrographs 
showing ultrastructure of tumor tissue. Arrows indicate double-membraned autophagic vacuoles (magnification, ×20000). (B) Quantification of autophagic 
vacuoles in tumor cells was performed. The number of autophagic vacuoles in each cell was counted. The data are mean±SEM (*p<0.05). N, no recurrence; 
R, recurrence; SEM, standard error of mean.
Fig. 2. Decreased p62/SQSTM1 correlates with treatment failure of pulmonary metastasis in colorectal cancer patients. (A) Western blot analysis for p62/
SQSTM1 in tumors of CRC patients. The p62/SQSTM1 expressions of tumor tissue from patients who had experienced recurrence showed trends of lower 
levels than tissues from patients who had no recurrence. (B) Expression intensity of Western blot was measured by image J program. The data are 
mean±SEM (p=0.201). CRC, colorectal cancer; SEM, standard error of mean.
Fig. 3. Autophagy activity (LC3II) of peri-tumor tissue shows no difference between no recurrence and recurrence group. (A) Western blot analysis for LC3B-
II protein in peri-tumors of CRC patients. The levels of LC3B-II were not different in both no recurrence and recurrence group. (B) Expression intensity of 
Western blot was measured by image J program. The data are mean±SEM (p=0.797). CRC, colorectal cancer; SEM, standard error of mean.
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SQSTM1 degradation can be used as an another marker of 
autophagy flux.17 To assess the autophagy activity, there-
fore, monitoring of protein levels of LC3B-II and p62/
SQSTM1 by Western blot and confirming the ultrastructure 
of autophagic vacuoles by electron microscopy are essen-
tial, as described in the present study. Recently, autophagy 
has been suggested to explain for the mechanism of treat-
ment resistance in cancer patients. However, the role of au-
tophagy in tumor is controversial, and has commonly been 
described as a double-edged sword because it functions 
both as a tumor suppressor and a protector of cancer cell.9,10 
Specifically, after a tumor develops, autophagy acts to sup-
port the persistence of the tumor. According to many stud-
ies, autophagy activities are enhanced in response to treat-
ment such as chemotherapy and radiation, contributing to 
treatment resistance in cancer cell.9-12 In addition, autopha-
gy has been reported to correlate with tumor aggressive-
ness, including tumor differentiation, growth pattern of the 
tumor margin, pN, pstage as well as vessel and nerve plex-
us invasion in colorectal cancer.13 In the present study, we 
showed that autophagy was enhanced in recurrence group. 
This might be related with chemotherapy resistance or tu-
mor aggressiveness. However, we could not confirm under-
lying mechanism of this treatment failure. To assess the un-
derlying mechanism, further study is needed with more 
patient data.
Most of the understanding on the role of autophagy in 
cancer have come from the studies with cancer cell lines ex-
pressing autophagy markers. There is, however, little knowl-
edge regarding the autophagy in clinical tumor samples; es-
pecially the extent of which varies depending on tumor 
tissues. To test our hypothesis, therefore, we measured au-
tophagy activity in tumor tissues obtained from pulmonary 
metastasis of colorectal cancer patients who were followed 
up for over one year. To the best of our knowledge, this is 
the first report on enhanced autophagy activity in human 
metastatic lung cancer tissue.
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